Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Cogna Technology Solutions

1 clinical trial

Clinical trial
An Observer-Blinded Phase 3 Study to Evaluate the Safety and Immunogenicity of a Single Booster of the NVX-CoV2373 Vaccine in Adults Previously Vaccinated With the BBIBP-CorV Vaccine
Status: Completed, Estimated PCD: 2023-05-04